Familial Alzheimer's Disease - the Fenton reaction

Author： Velez-Pardo C. Del Rio M.J. Lopera F.

Publisher： Elsevier

ISSN： 0306-3623

Source： General Pharmacology, Vol.31, Iss.5, 1998-11, pp. : 675-681

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Galantamine for Alzheimer's disease

By Prvulovic David Hampel Harald Pantel Johannes

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 3, 2010-03 ,pp. : 345-354

Informa Healthcare

Access to resources Recommend Favorite

Inflammatory processes in Alzheimer's disease

By McGeer E.G. McGeer P.L.

Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 27, Iss. 5, 2003-08 ,pp. : 741-749

Elsevier

Access to resources Recommend Favorite

Neuropeptides and Alzheimer's disease

By Gottfries C.-G. Frederiksen S.O. Heilig M.

European Neuropsychopharmacology, Vol. 5, Iss. 4, 1995-12 ,pp. : 491-500

Elsevier

Access to resources Recommend Favorite

Treatment strategies in Alzheimer's disease

By Levy R.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 204-205

Elsevier

Access to resources Recommend Favorite

Combination Therapy for Alzheimer's Disease

By Patel Laxeshkumar Grossberg George T.

Drugs & Aging, Vol. 28, Iss. 7, 2011-07 ,pp. : 539-546

Adis International

Access to resources Recommend Favorite